Background Muscular weakness and/or muscle wasting is recognized as a key medical
problem in critically ill patients on intensive care units (ICUs) worldwide. Methods and …

Critical illness polyneuropathies (CIP) and myopathies (CIM) are common complications of
critical illness. Several weakness syndromes are summarized under the term intensive care …

Neuromuscular dysfunction is prevalent in critically ill patients, is associated with worse
short-term outcomes, and is a determinant of long-term disability in intensive care unit …

An acute myopathy of intensive care occurs in critically ill patients treated with intravenous
corticosteroids and neuromuscular junction‐blocking agents. The full clinicopathological …

The spectrum of neuromuscular disorders among intensive care unit (ICU) patients has
shifted toward disorders acquired within the ICU and away from “traditional” neuromuscular …

Rationale: Critical illness myopathy (CIM) has no known cause and no treatment.
Immobilization and impaired glucose metabolism are implicated. Objectives: We assessed …

Chronic critical illness is a global clinical issue affecting millions of sepsis survivors
annually. Survivors report chronic skeletal muscle weakness and development of new …

Anomaly detection in medical images refers to the identification of abnormal images with
only normal images in the training set. Most existing methods solve this problem with a self …

Acute myopathy is a cause of weakness and additional morbidity in a variety of critically ill
patients, including transplant recipients. We report the incidence of and risk factors …

Drugs are prescribed to manage or prevent symptoms and diseases, but may sometimes
cause unexpected toxicity to muscles. The symptomatology and clinical manifestations of the …